- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 583.88M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $9.28K |
| Capex | Q1 2026 · Mar 31, 2025 | $1.08K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$126.17K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $267.88K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.41M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.55M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$43.62M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$43.01M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$41.2M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$40.43M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $47.47M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $46.69M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $48.41M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $47.65M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.43M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.21M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.79M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.64M |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $525.27K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $683.19K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $620.54K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $580.39K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$756.2K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$920.8K |
| Operating Income | Q1 2026 · Mar 31, 2026 | $30.84K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$134.71K |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.19M |
| Revenue | Q1 2026 · Mar 31, 2025 | $2.24M |